On Wednesday, NORML and Washington NORML both submitted public comment to the Washington State Liquor and Cannabis Board (WSLCB) in support of the regulatory body drafting model legislation to allow the lawful home cultivation of marijuana for personal use.
In their second formal assessment on the impact of legalization in the wake of the implementation of I-502, the Washington State Institute for Public Policy (WSIPP) issued the next regularly scheduled report – and suffice to say, the news was very positive, unless you are still relying on tired and debunked prohibitionist talking points.
For more than a year, The American Legion has been calling on the federal government – and specifically the Veterans Affairs Department – to support research into the therapeutic benefits of cannabis in treating veterans with PTSD. Now, the Legion is ramping up their efforts to convince VA Secretary Shulkin to expand research into the therapeutic and medicinal effects of cannabis.
Earlier this month, citing racism, bigotry, and mass-incarceration, the Pennsylvania Democratic Party adopted a resolution to “support Democratic candidates and policies which promote the full repeal of cannabis prohibition by its removal from the Controlled Substances Act, and to support the creation of new laws which regulate it in a manner similar to other culturally accepted commodities.”
By the numbers:
– 140+ attendees
– 21 speakers
– 5 members of Congress
– 150+ congressional meetings
– 1 goal: End marijuana prohibition.
In a quick deal between President Trump and Congress, a three-month budget continuing resolution will be in effect until December 8, 2017, maintaining current spending levels.
While this seems mundane (it is), it is important for marijuana policy because it guarantees a temporary extension of the Rohrabacher-Blumenauer protections for lawful medical marijuana programs from Attorney General Jeff Sessions.
Late Wednesday night, the House Rules Committee led by prohibitionist Representative Pete Sessions (R-TX) blocked multiple amendments related to marijuana from receiving consideration by the full House, thus ending their consideration and silencing the ability for the lower chamber to offer protections from Attorney General Jeff Sessions when it comes to cannabis.
On Regulations.Gov, right now, the Federal Food and Drug Administration (FDA) is soliciting public comments with regard to the therapeutic utility and abuse liability of various controlled substances, including cannabidiol (CBD).